{"id":832275,"date":"2026-08-26T18:10:02","date_gmt":"2026-08-26T18:10:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=832275"},"modified":"2026-08-26T18:10:02","modified_gmt":"2026-08-26T18:10:02","slug":"overactive-bladder-treatment-market-size-to-reach-usd-472-billion-by-2031-supported-by-growing-demand-for-beta3-agonists-and-devicebased-therapies","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/overactive-bladder-treatment-market-size-to-reach-usd-472-billion-by-2031-supported-by-growing-demand-for-beta3-agonists-and-devicebased-therapies_832275.html","title":{"rendered":"Overactive Bladder Treatment Market Size to Reach USD 4.72 Billion by 2031, Supported by Growing Demand for Beta-3 Agonists and Device-Based Therapies"},"content":{"rendered":"
\"Overactive<\/a><\/div>\n
Mordor Intelligence has published a new report on the Overactive Bladder Treatment Market, offering a comprehensive analysis of market trends, growth drivers, segmentation, and future projections.<\/div>\n

Hyderabad, India – Aug 26, 2026<\/strong> – According to Mordor Intelligence, the Overactive Bladder Treatment Market size is estimated at USD 4 billion in 2026 and is projected to reach USD 4.72 billion by 2031, growing at a CAGR of 3.38% during the forecast period. The market is supported by an aging population, increasing prevalence of urinary disorders, growing use of beta-3 adrenergic agonists, and wider adoption of device-based treatments.<\/p>\n

Overactive bladder treatment includes pharmacological therapies, device-based neuromodulation systems, and botulinum toxin injections used to manage urgency, frequency, and urge incontinence in adults with idiopathic or neurogenic overactive bladder. The Overactive Bladder Treatment Market growth is also being supported by expanding reimbursement for neuromodulation and botulinum toxin procedures, along with increasing use of tele-urology and digital diagnostic tools.<\/p>\n

Report Overview: https:\/\/www.mordorintelligence.com\/industry-reports\/overactive-bladder-treatment-market?utm_source=abnewswire<\/a><\/p>\n

Overactive Bladder Treatment Market Trends<\/p>\n

Growing Adoption of Beta-3 Adrenergic Agonists<\/p>\n

One of the most important Overactive Bladder Treatment Market trends is the increasing use of beta-3 adrenergic agonists. These therapies are gaining attention as healthcare professionals consider treatment options with a more favorable cognitive safety profile. The availability of newer indications is also expanding the patient population that can be treated with this class of medicines.<\/p>\n

The growing use of beta-3 agonists is changing the treatment mix within the Overactive Bladder Treatment industry, while anticholinergics continue to serve a large patient population. Concerns regarding the cognitive effects associated with long-term anticholinergic use are encouraging healthcare professionals to consider alternative treatment options, particularly among older patients.<\/p>\n

Increasing Demand for Device-Based Treatments<\/p>\n

Device-based treatment is another important area supporting the Overactive Bladder Treatment Market growth. Neuromodulation and sacral stimulation are increasingly being considered for patients who require alternatives to conventional pharmacological treatment. Improvements in device design and broader reimbursement are helping expand the use of these therapies.<\/p>\n

Botulinum toxin injections also remain an important option for patients with persistent symptoms. Increased reimbursement and treatment pathways for patients who do not respond adequately to conservative or pharmacological approaches are supporting demand for these interventions.<\/p>\n

Rising Use of Tele-Urology and Digital Diagnostics<\/p>\n

Digital healthcare is becoming increasingly relevant to the Overactive Bladder Treatment Market forecast. Tele-urology services and digital diagnostic tools can help connect patients with specialists, particularly where access to urologists is limited. Remote monitoring can also support follow-up care, symptom tracking, and treatment adherence.<\/p>\n

The use of digital tools is particularly relevant to older patients and individuals living in areas where specialist services are less readily available. These developments are creating additional opportunities for healthcare providers to manage overactive bladder outside traditional hospital settings.<\/p>\n

Growing Need for Treatment Among Aging Populations<\/p>\n

An aging population remains an important factor influencing the Overactive Bladder Treatment Market size. The prevalence of overactive bladder increases with age, creating sustained demand for treatment options that can manage urinary urgency, frequency, and urge incontinence.<\/p>\n

Healthcare systems are therefore placing greater attention on long-term symptom management and treatment options suited to older adults. This demographic trend is expected to continue supporting demand across pharmaceutical and device-based treatment categories.<\/p>\n

Overactive Bladder Treatment Market Segmentation<\/p>\n

The Overactive Bladder Treatment Market is segmented by therapy, disease type, route of administration, end user, and geography.<\/p>\n

By Therapy<\/p>\n

The market includes:<\/p>\n